TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director September 3, 1976
TCL Archive Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More March 29, 1996